Thomas Jefferson University: Breast Neoplasms trials
The registry lists 18 Breast Neoplasms studies with Thomas Jefferson University as lead sponsor. 4 are open to participants now and 1 have results posted.
Early Phase 1 1Phase 1 2Phase 2 1Phase 4 1No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Tai Chi for Reducing Aromatase Inhibitor-Induced ArthralgiaRecruitingNCT07737951Not applicable
- EXploring Inflammation and Social deTerminants Study in Breast Cancer PatientsRecruitingNCT07478016
- Surviving Daily LifeRecruitingNCT07054723
- Prospective Breast Cancer Biospecimen CollectionRecruitingNCT04074720
- Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast CancerCompletedNCT04721886Early Phase 1Results posted
- MBC Physical Activity StudyCompletedNCT06500858Not applicable
- An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung CancerTerminatedNCT06315296Not applicable
- Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast CancerCompletedNCT06219434Not applicable
- Evaluation of Barriers to Cancer Care Delivery and Outcomes for Women of Color With Metastatic Breast CancerCompletedNCT06206239
- A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast CancerCompletedNCT05408260Not applicable
- Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint TrialCompletedNCT04716920Not applicable
- Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast CancerWithdrawnNCT04418219Phase 1/2
- A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast CancerActive, not recruitingNCT04086875Not applicable
- Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy AdherenceCompletedNCT04054557Not applicable
- Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall RecurrencesTerminatedNCT03955640Phase 1
- Contrast Enhanced Mammography in Diagnosing Patients With Suspicious Breast FindingsCompletedNCT03929783Not applicable
- Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast CancerStatus unknownNCT01514565
- Wellbutrin XL, Major Depressive Disorder and Breast CancerCompletedNCT00234195Phase 4